This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Tandem Diabetes Care, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Brendan Nichols - Innovator in Automated Insulin Delivery Systems
Introduction
Brendan Nichols is a notable inventor based in San Diego, CA, who has made significant contributions to the field of medical technology. He holds a patent for a groundbreaking system designed to enhance insulin delivery for individuals with diabetes. His work focuses on improving the accuracy and reliability of automated insulin delivery systems.
Latest Patents
Brendan Nichols is credited with 1 patent, titled "Systems and methods for automated insulin delivery response to inaccurate or missed glucose values." This patent discloses systems and methods that incorporate an ambulatory infusion pump and a continuous glucose monitor (CGM). The innovative systems include software and related methods that provide improved automated insulin delivery algorithms. These algorithms are designed to safely continue delivering insulin even during periods of missing or known inaccurate glucose values.
Career Highlights
Brendan Nichols is currently employed at Tandem Diabetes Care, Inc., a company dedicated to developing advanced diabetes management solutions. His work at Tandem has positioned him as a key player in the evolution of diabetes care technology. His contributions are vital in addressing the challenges faced by individuals managing diabetes.
Collaborations
Brendan has collaborated with talented professionals in his field, including Thomas R. Ulrich and Jacob Kearns. These collaborations have fostered an environment of innovation and have led to the development of cutting-edge solutions in diabetes management.
Conclusion
Brendan Nichols is a pioneering inventor whose work in automated insulin delivery systems is making a significant impact on diabetes care. His innovative approach and dedication to improving patient outcomes highlight the importance of advancements in medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
